CHARLES WILLIAM STRATTON, MD
Medical Practice in Nashville, TN
License number
Tennessee MD11948
Category
Osteopathic Medicine
Type
Infectious Disease
License number
Tennessee MD0000011948
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
Address
Address
1301 Medical Center Dr Vumc ROOM 4525-TVC, Nashville, TN 37232
Phone
(615) 343-9144
(615) 343-8420 (Fax)
(615) 343-8420 (Fax)
Professional information
Dr. Charles W Stratton, Nashville TN - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine, Medical Microbiology
Address:
Vanderbilt Univ Med Ctr Pathlgy
4605 The Vanderbilt Clinic, Nashville 37232
(615) 322-0126 (Phone)
4605 The Vanderbilt Clinic, Nashville 37232
(615) 322-0126 (Phone)
Certifications:
Infectious Disease, 1976, Internal Medicine, 1974, Medical Microbiology, 1978
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Vanderbilt Univ Med Ctr Pathlgy
4605 The Vanderbilt Clinic, Nashville 37232
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232
4605 The Vanderbilt Clinic, Nashville 37232
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232
Education:
Medical School
University of Vermont / College of Medicine
Graduated: 1971
Vermont Med Ctr Hosp
Colo Med Ctr
University of Vermont / College of Medicine
Graduated: 1971
Vermont Med Ctr Hosp
Colo Med Ctr
Methods And Treatment Of Multiple Sclerosis
US Patent:
6710033, Mar 23, 2004
Filed:
Mar 17, 2000
Appl. No.:
09/528348
Inventors:
Charles W. Stratton - Nashville TN
William M. Mitchell - Nashville TN
Subramaniam Sriram - Nashville TN
William M. Mitchell - Nashville TN
Subramaniam Sriram - Nashville TN
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A61K 3170
US Classification:
514 29, 514 31, 514311, 514312, 514313, 514314, 514398, 514903
Abstract:
The invention features methods and reagents for the diagnosis, monitoring, and treatment of multiple sclerosis. The invention is based in part on the discovery that Chlamydia is present in patients with multiple sclerosis, and that anti-chlamydial agents improve or sustain neurological function in these patients.
Diagnosis And Management Of Infection Caused By Chlamydia
US Patent:
6756369, Jun 29, 2004
Filed:
Mar 19, 2002
Appl. No.:
10/101279
Inventors:
William M. Mitchell - Nashville TN
Charles W. Stratton - Nashville TN
Charles W. Stratton - Nashville TN
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A61K 3143
US Classification:
514199, 514 30, 514 31, 514192, 514393, 514394, 514395, 514562, 514826
Abstract:
The present invention provides a unique approach for the diagnosis and management of infections by Chlamydia species, particularly. The invention is based, in part, upon the discovery that a combination of agents directed toward the various stages of the chlamydial life cycle is effective in substantially reducing infection. Products comprising combination of antichlamydial agents, novel compositions and pharmaceutical packs are also described.
Diagnosis And Management Of Infection Caused By Chlamydia
US Patent:
6664239, Dec 16, 2003
Filed:
Mar 19, 2002
Appl. No.:
10/100785
Inventors:
William M. Mitchell - Nashville TN
Charles W. Stratton - Nashville TN
Charles W. Stratton - Nashville TN
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A61K 3170
US Classification:
514 29, 514 31, 514152, 514179, 514192, 514199, 514311, 514312, 514601
Abstract:
The present invention provides a unique approach for the diagnosis and management of infections by Chlamydia species, particularly. The invention is based, in part, upon the discovery that a combination of agents directed toward the various stages of the chlamydial life cycle is effective in substantially reducing infection. Products comprising combination of antichlamydial agents, novel compositions and pharmaceutical packs are also described.
Diagnosis And Management Of Infection Caused By Chlamydia
US Patent:
6838552, Jan 4, 2005
Filed:
Nov 8, 2000
Appl. No.:
09/709201
Inventors:
William M. Mitchell - Nashville TN, US
Charles W. Stratton - Nashville TN, US
Charles W. Stratton - Nashville TN, US
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A61K 5100, A61K 39118, A61B 5055, G01N 3355, G01N 33567
US Classification:
5303895, 424 149, 424 934, 4242631, 435 71, 435 72, 435 732, 435 736, 435 78, 435 792, 435 793, 435 794, 435 795, 436512, 436532, 436535, 436545, 436546, 5303871, 5303879, 5303884
Abstract:
The present invention provides a unique approach for the diagnosis and management of infections by Chlamydia species, particularly. The invention is based, in part, upon the discovery that a combination of agents directed toward the various stages of the chlamydial life cycle is effective in substantially reducing infection. Products comprising combination of antichlamydial agents, novel compositions and pharmaceutical packs are also described.
Diagnosis And Management Of Infection Caused By Chlamydia
US Patent:
2005004, Feb 24, 2005
Filed:
Jun 22, 2004
Appl. No.:
10/873768
Inventors:
William Mitchell - Nashville TN, US
Charles Stratton - Nashville TN, US
Charles Stratton - Nashville TN, US
International Classification:
C12Q001/70, G01N033/53, G01N033/567
US Classification:
435007200
Abstract:
The present invention provides a unique approach for the diagnosis and management of infections by species, particularly . The invention is based, in part, upon the discovery that a combination of agents directed toward the various stages of the life cycle is effective in substantially reducing infection. Products comprising combination of antichlamydial agents, novel compositions and pharmaceutical packs are also described.
Diagnosis And Management Of Infection Caused By Chlamydia
US Patent:
2005014, Jun 30, 2005
Filed:
Feb 8, 2005
Appl. No.:
11/053027
Inventors:
William Mitchell - Nashville TN, US
Charles Stratton - Nashville TN, US
Charles Stratton - Nashville TN, US
Assignee:
Vanderbuilt University - Nashville TN
International Classification:
A61K031/7052, A61K031/573, A61K031/496, A61K031/4709, A61K031/192
US Classification:
514252130, 514253080, 514312000, 514171000, 514028000, 514570000
Abstract:
The present invention provides a method of treating coronary artery disease in a patient in need thereof by administering to the patient an antichlamydial amount of a rifamycin for a duration to treat said coronary artery disease.
Identification Of Antigenic Peptide Sequences
US Patent:
2003017, Sep 18, 2003
Filed:
Dec 14, 2001
Appl. No.:
10/020269
Inventors:
William Mitchell - Nashville TN, US
Charles Stratton - Nashville TN, US
Charles Stratton - Nashville TN, US
International Classification:
A61K039/118, C07H021/04, C07K014/295, C07K016/12
US Classification:
424/263100, 530/350000, 530/388400, 536/023700
Abstract:
Identification of linear amino acid antigenic sequences for the production of both polyclonal and monoclonal antibodies to defined antigenic domains is described. Also described are antigenic peptides identified by the described methods and antibodies thereto.
Anti-Chlamydial Antibodies And Uses Thereof
US Patent:
2006007, Apr 6, 2006
Filed:
Oct 18, 2005
Appl. No.:
11/252479
Inventors:
William Mitchell - Nashville TN, US
Charles Stratton - Nashville TN, US
Charles Stratton - Nashville TN, US
Assignee:
Vanderbilt University - Nashville TN
International Classification:
G01N 33/554, G01N 33/569, C07K 16/12
US Classification:
435007320, 530388400
Abstract:
The invention relates to anti-chlamydial antibodies and uses of anti-chlamydial antibodies for detection of the presence of
Isolated Polynucleotides
US Patent:
8445661, May 21, 2013
Filed:
Nov 9, 2007
Appl. No.:
12/514268
Inventors:
Yi-Wei Tang - Brentwood TN, US
Charles W. Stratton - Nashville TN, US
Jian Han - Huntsville AL, US
Charles W. Stratton - Nashville TN, US
Jian Han - Huntsville AL, US
Assignee:
Qiagen Sciences, LLC
Vanderbilt University - Nashville TN
Vanderbilt University - Nashville TN
International Classification:
C07H 21/02, C07H 21/04
US Classification:
536 237, 536 231, 536 2432, 536 2433
Abstract:
Disclosed is an isolated strain of a previously unknown. Also disclosed are the sequences of the tuf gene and 16s rRNA and methods for distinguishing from other staphylococcal species.